UNSPSC 85816327: Introduction of low-dose interleukin-2 into peripheral vein, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of low-dose interleukin-2 into peripheral vein, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E03303

UNSPSC 85816327, Introduction of low-dose interleukin-2 into peripheral vein, percutaneous approach, is a Commodity code that sits at a significant disconnect from the recent state and local procurement activity tagged under it. The code nominally describes a specific clinical procedure—administering interleukin-2 therapy intravenously—yet the actual opportunities recorded do not solicit this service or anything closely related to it.

The recent opportunities in the dataset span virtual urgent care services, nursing home placement beds, employee health clinics, cancer screening and registry services, occupational health evaluations, EMS revenue billing, orthotic equipment, psychological evaluation, substance use disorder treatment, opioid abatement and recovery programming, and temporary health professional staffing across jurisdictions including California, Georgia, Nevada, Colorado, Florida, Texas, Kansas, and others. None of these scopes include interleukin-2 infusion or similar immunotherapy administration. The code shows no decision-relevant activity for a vendor pursuing clinical immunotherapy services at the state and local level. If your firm provides low-dose IL-2 therapy or related biopharmaceutical administration services, this code does not currently represent an active procurement market in state and local government.